Table 1 Clinicopathological characteristics of patients for clinical validation cohorts.

From: Genome-scale analysis identifies NEK2, DLGAP5 and ECT2 as promising diagnostic and prognostic biomarkers in human lung cancer

Clinical and pathological variables

Clinical validation cohorts (N = 56)

Age (years)

 <60

29

 ≥60

27

Gender

 Male

54

 Female

2

Smoking status

 Smoker

48

 Non-smoker

8

Clinical stage

 I-II

28

 III-IV

28

Differentiation

 Well

8

 Moderate

27

 Poor

21

Lymph node metastasis

 Yes

21

 No

35